Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment

Jennifer R. Havens; Sharon L. Walsh; P. Todd Korthuis; David A. Fiellin

doi:10.1007/s11904-018-0402-3

Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment

Jennifer R. Havens, Sharon L. Walsh, P. Todd Korthuis, David A. Fiellin

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

Abstract

Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

Original language	English
Pages (from-to)	315-323
Number of pages	9
Journal	Current HIV/AIDS Reports
Volume	15
Issue number	4
DOIs	https://doi.org/10.1007/s11904-018-0402-3
State	Published - Aug 1 2018

Bibliographical note

Funding Information:
Funding Dr. Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815).

Funding Information:
Conflict of Interest P. Todd Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815).

Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

HIV
Hepatitis C
Opioid treatment
Opioid treatment programs

ASJC Scopus subject areas

Virology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11904-018-0402-3

Cite this

@article{67ece83fdedc4c6cbc61b12db71805da,

title = "Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment",

abstract = "Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.",

keywords = "HIV, Hepatitis C, Opioid treatment, Opioid treatment programs",

author = "Havens, {Jennifer R.} and Walsh, {Sharon L.} and Korthuis, {P. Todd} and Fiellin, {David A.}",

note = "Funding Information: Funding Dr. Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815). Funding Information: Conflict of Interest P. Todd Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815). Publisher Copyright: {\textcopyright} 2018, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2018",

month = aug,

day = "1",

doi = "10.1007/s11904-018-0402-3",

language = "English",

volume = "15",

pages = "315--323",

number = "4",

}

TY - JOUR

T1 - Implementing Treatment of Opioid-Use Disorder in Rural Settings

T2 - a Focus on HIV and Hepatitis C Prevention and Treatment

AU - Havens, Jennifer R.

AU - Walsh, Sharon L.

AU - Korthuis, P. Todd

AU - Fiellin, David A.

N1 - Funding Information: Funding Dr. Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815). Funding Information: Conflict of Interest P. Todd Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815). Publisher Copyright: © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

AB - Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

KW - HIV

KW - Hepatitis C

KW - Opioid treatment

KW - Opioid treatment programs

UR - http://www.scopus.com/inward/record.url?scp=85048266359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048266359&partnerID=8YFLogxK

U2 - 10.1007/s11904-018-0402-3

DO - 10.1007/s11904-018-0402-3

M3 - Review article

C2 - 29948609

AN - SCOPUS:85048266359

SN - 1548-3568

VL - 15

SP - 315

EP - 323

JO - Current HIV/AIDS Reports

JF - Current HIV/AIDS Reports

IS - 4

ER -

Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this